or Try an Advanced Search...

    Technical Analysis for KVUE - Kenvue Inc.

    Grade Last Price % Change Price Change
    C 20.47 -0.63% -0.13
    KVUE closed down 0.63 percent on Friday, May 17, 2024, on 1.54 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical KVUE trend table...
    Date Alert Name Type % Chg
    Gapped Up Strength 0.00%
    Overbought Stochastic Strength 0.00%
    Cup with Handle Other -0.63%
    Volume Surge Other -0.63%
    Overbought Stochastic Strength -0.63%
    Cup with Handle Other -0.34%
    Volume Surge Other -0.34%
    Upper Bollinger Band Walk Strength -0.34%
    Overbought Stochastic Strength -0.34%
    Gapped Down Weakness -0.34%
    Older End-of-Day Signals for KVUE ...

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    KVUE Chart by TradingView
    Basic chart:

    Profile

    Kenvue Inc. Description

    Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products primarily under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products primarily under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby care, women's health, and wound care products primarily under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.

    Classification
    Sector: Consumer Defensive
    Industry: Household & Personal Products
    Keywords: S&P 500 Pain Skin Care Allergy Cough Care Products Self Care Wound Care Products Johnson & Johnson

    Is KVUE a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 15 Kenvue prices secondary stock offering as Johnson & Johnson exits
    May 14 Kenvue Announces Pricing of Secondary Offering
    May 13 CPI expectations, GameStop stock, EV slowdown: Catalysts
    May 13 Johnson & Johnson to sell remaining stake in Kenvue
    May 13 Johnson & Johnson to exit Kenvue in debt-for-equity deal
    May 13 Kenvue Announces Launch of Secondary Offering
    May 8 Kenvue First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
    May 8 Kenvue Inc (KVUE) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Operational ...
    May 7 Kenvue (KVUE) Q1 2024 Earnings Call Transcript
    May 7 Kenvue Inc. (KVUE) Q1 2024 Earnings Call Transcript
    See more KVUE news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 26.3629
    52 Week Low 17.2728
    Average Volume 20,181,722
    200-Day Moving Average 20.09
    50-Day Moving Average 19.84
    20-Day Moving Average 19.60
    10-Day Moving Average 20.31
    Average True Range 0.46
    RSI (14) 61.69
    ADX 27.02
    +DI 26.67
    -DI 16.54
    Chandelier Exit (Long, 3 ATRs) 19.58
    Chandelier Exit (Short, 3 ATRs) 19.81
    Upper Bollinger Bands 21.21
    Lower Bollinger Band 18.00
    Percent B (%b) 0.77
    BandWidth 16.40
    MACD Line 0.30
    MACD Signal Line 0.15
    MACD Histogram 0.1531
    Fundamentals Value
    Market Cap 39.2 Billion
    Num Shares 1.92 Billion
    EPS 0.90
    Price-to-Earnings (P/E) Ratio 22.74
    Price-to-Sales 2.43
    Price-to-Book 3.40
    Dividend 0.40
    Dividend Yield 1.95%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 21.01
    Resistance 3 (R3) 21.04 20.89 20.92
    Resistance 2 (R2) 20.89 20.75 20.88 20.89
    Resistance 1 (R1) 20.68 20.67 20.61 20.65 20.86
    Pivot Point 20.53 20.53 20.49 20.52 20.53
    Support 1 (S1) 20.32 20.39 20.25 20.29 20.08
    Support 2 (S2) 20.17 20.31 20.16 20.05
    Support 3 (S3) 19.96 20.17 20.02
    Support 4 (S4) 19.93